DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Alphagan P (Brimonidine Ophthalmic) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (1)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Alphagan P (Brimonidine Ophthalmic) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Alphagan P side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-15

Patient: female, weighing 53.1 kg (116.8 pounds)

Reactions: Confusional State, Glaucoma, Optic Nerve Disorder, Ileostomy, Drug Interaction, Impaired Driving Ability, Malaise, Skin Discolouration, Procedural Pain, Dyspnoea, Vomiting, Visual Field Defect, Condition Aggravated, Toxicity To Various Agents, Amnesia, Tremor, Diarrhoea, Dysuria, Blindness

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Ethambutol Hydrochloride
    Dosage: 500 mg;bid
    Indication: Mycobacterium Avium Complex Infection
    End date: 2008-06-01

Ethambutol Hydrochloride
    Dosage: 500 mg;bid
    Indication: Eye Infection Bacterial
    End date: 2008-06-01

3 Antibiotics (Unspecified) (NO Pref. Name)
    Start date: 2012-01-01

Amikacin
    Start date: 2012-01-01
    End date: 2012-01-01

Alphagan P
    Indication: Mycobacterium Avium Complex Infection
    Start date: 2000-01-01

Alphagan P
    Indication: Eye Infection Bacterial
    Start date: 2000-01-01

Morphine
    Start date: 2010-10-01

Other drugs received by patient: Keflex; Vantin; Amoxicillin; Ciprofloxacin; Rifampin; Duragesic-100; Phenazopyridine HCL TAB; Biaxin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017